Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Telo Genomics Corp
(OP:
TDSGF
)
0.0385
-0.0015 (-3.75%)
Streaming Delayed Price
Updated: 12:09 PM EDT, Oct 29, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
5,000
Open
0.0365
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
0.0400
Today's Range
0.0365 - 0.0385
52wk Range
0.0400 - 0.1220
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
OTCQB Venture Virtual Investor Conference: Presentations Now Available for Online Viewing
August 08, 2025
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
Telo Genomics to Present at the OTCQB Venture Virtual Investor Conference
August 05, 2025
From
Virtual Investor Conferences
Via
GlobeNewswire
Performance
YTD
-52.5%
-52.5%
1 Month
-13.7%
-13.7%
3 Month
-30.9%
-30.9%
6 Month
-33.8%
-33.8%
1 Year
-63.4%
-63.4%
More News
Read More
OTCQB Venture Virtual Investor Conference Agenda Announced for August 7th
August 04, 2025
From
Virtual Investor Conferences
Via
GlobeNewswire
EXCLUSIVE: Telo Genomics' Smoldering Multiple Myeloma Prognostic Test Predicts Risk Of Disease Progression, Study Shows
May 30, 2024
Via
Benzinga
Telo Genomics Completes International Standards Organization ("ISO") 15189 Final Accreditation
October 26, 2023
Via
Newsfile
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030
January 30, 2024
Via
FinancialNewsMedia
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030
October 17, 2023
Via
FinancialNewsMedia
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030
January 30, 2024
From
FN Media Group LLC
Via
GlobeNewswire
Telo Genomics Announces Clinical Launch of Non-Invasive Cancer Diagnostic, TeloViewSMM – An Important Commercial Milestone Achieved
October 17, 2023
Via
FinancialNewsMedia
Topics
Artificial Intelligence
Telo Genomics Presents Positive Results in Assessing MRD in Multiple Myeloma Patients at the International Myeloma Society Annual Meeting
October 12, 2023
Via
FinancialNewsMedia
Telo Genomics Announces Achieving Interim Results from Smouldering Myeloma Clinical Study
September 14, 2022
Via
Newsfile
Frequently Asked Questions
Is Telo Genomics Corp publicly traded?
Yes, Telo Genomics Corp is publicly traded.
What exchange does Telo Genomics Corp trade on?
Telo Genomics Corp trades on the OTC Traded
What is the ticker symbol for Telo Genomics Corp?
The ticker symbol for Telo Genomics Corp is TDSGF on the OTC Traded
What is the current price of Telo Genomics Corp?
The current price of Telo Genomics Corp is 0.0385
When was Telo Genomics Corp last traded?
The last trade of Telo Genomics Corp was at 10/29/25 12:09 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.